01-01-2002 | ORIGINAL COMMUNICATION
A randomized, double-masked, crossover comparison of the efficacy and safety of botulinum toxin type A produced from the original bulk toxin source and current bulk toxin source for the treatment of cervical dystonia
Published in: Journal of Neurology | Issue 1/2002
Login to get access